Germany · Delayed Price · Currency is EUR Celldex Therapeutics Statistics
Total Valuation
FRA:TCE2 has a market cap or net worth of EUR 1.48 billion. The enterprise value is 982.15 million.
| Market Cap | 1.48B |
| Enterprise Value | 982.15M |
Important Dates
The next estimated earnings date is Monday, February 23, 2026.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.45M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.16% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 95.19% |
| Float | 56.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 668.85 |
| PB Ratio | 2.91 |
| P/TBV Ratio | 3.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.34 |
Financial Position
The company has a current ratio of 13.01, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.01 |
| Quick Ratio | 12.55 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.44% and return on invested capital (ROIC) is -23.04%.
| Return on Equity (ROE) | -32.44% |
| Return on Assets (ROA) | -21.77% |
| Return on Invested Capital (ROIC) | -23.04% |
| Return on Capital Employed (ROCE) | -42.57% |
| Revenue Per Employee | 11,909 |
| Profits Per Employee | -1.03M |
| Employee Count | 186 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -12.21% |
| 50-Day Moving Average | 22.05 |
| 200-Day Moving Average | 19.25 |
| Relative Strength Index (RSI) | 59.19 |
| Average Volume (20 Days) | 7 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.73 |
Income Statement
In the last 12 months, FRA:TCE2 had revenue of EUR 2.22 million and -191.37 million in losses. Loss per share was -2.88.
| Revenue | 2.22M |
| Gross Profit | -182.46M |
| Operating Income | -218.39M |
| Pretax Income | -191.37M |
| Net Income | -191.37M |
| EBITDA | -215.51M |
| EBIT | -218.39M |
| Loss Per Share | -2.88 |
Balance Sheet
The company has 497.08 million in cash and 2.23 million in debt, giving a net cash position of 494.85 million.
| Cash & Cash Equivalents | 497.08M |
| Total Debt | 2.23M |
| Net Cash | 494.85M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 509.98M |
| Book Value Per Share | 7.68 |
| Working Capital | 475.48M |
Cash Flow
In the last 12 months, operating cash flow was -152.97 million and capital expenditures -1.87 million, giving a free cash flow of -154.84 million.
| Operating Cash Flow | -152.97M |
| Capital Expenditures | -1.87M |
| Free Cash Flow | -154.84M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -9,859.21% |
| Pretax Margin | -8,639.17% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:TCE2 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.16% |
| Shareholder Yield | -9.16% |
| Earnings Yield | -12.92% |
| FCF Yield | -10.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Feb 11, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
FRA:TCE2 has an Altman Z-Score of 14.34 and a Piotroski F-Score of 1.
| Altman Z-Score | 14.34 |
| Piotroski F-Score | 1 |